Plasma ghrelin levels are normal in obese patients with idiopathic intracranial hypertension (pseudotumor cerebri)

American Journal of Ophthalmology

Volumn 138, Issue 1, 2004, Pages 109-113

  Subramanian, Prem S ^d   Goldenberg Cohen, Nitza ^a,e   Shukla, Salil ^a,f   Cheskin, Lawrence J ^a,b,c   Miller, Neil R ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d WALTER REED ARMY MEDICAL CENTER   (United States)

^e SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^f NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GHRELIN;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CLINICAL FEATURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEMOCONCENTRATION; HUMAN; IDIOPATHIC INTRACRANIAL HYPERTENSION; INTERMETHOD COMPARISON; INTRACRANIAL HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEAL; OBESITY; OUTPATIENT DEPARTMENT; OVERNUTRITION; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PSEUDOMOTOR CEREBRI; STANDARD; STATISTICAL SIGNIFICANCE; STOMACH SURGERY; UNIVERSITY HOSPITAL;

ADULT; BODY CONSTITUTION; BODY MASS INDEX; CASE-CONTROL STUDIES; FEMALE; GROWTH HORMONE; HUMANS; INSULIN; LEPTIN; MALE; MIDDLE AGED; OBESITY; PEPTIDE HORMONES; PROSPECTIVE STUDIES; PSEUDOTUMOR CEREBRI; WEIGHT LOSS;

EID: 3042758000     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2004.02.014     Document Type: Article

References (24)

1. Friedman D.I. Papilledema and pseudotumor cerebri. Ophthalmol Clin North Am. 14:2001;129-147
2. Radhakrishnan K., Sridharan R., Ashok P.P., Mousa M.E. Pseudotumour cerebri incidence and pattern in North-Eastern Libya. Eur Neurol. 25:1986;117-124
3. Durcan F.J., Corbett J.J., Wall M. The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana. Arch Neurol. 45:1988;875-877
4. Radhakrishnan K., Ahlskog J.E., Cross S.A., Kurland L.T., O'Fallon W.M. Idiopathic intracranial hypertension (pseudotumor cerebri). Descriptive epidemiology in Rochester, Minn, 1976 to 1990. Arch Neurol. 50:1993;78-80
5. Weisberg L.A. Benign intracranial hypertension. Medicine (Baltimore). 54:1975;197-207
6. Ireland B., Corbett J.J., Wallace R.B. The search for causes of idiopathic intracranial hypertension. A preliminary case-control study. Arch Neurol. 47:1990;315-320
7. Kesler A., Goldhammer Y., Gadoth N. Do men with pseudomotor cerebri share the same characteristics as women? A retrospective review of 141 cases. J Neuroophthalmol. 21:2001;15-17
8. Johnson L.N., Krohel G.G., Madsen R.W., March G.A. The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology. 105:1998;2313-2317
9. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 402:1999;656-660
10. Ariyasu H., Takaya K., Tagami T., et al. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab. 86:2001;4753-4758
11. Howard A.D., Feighner S.D., Cully D.F., et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science. 273:1996;974-977
12. Tschöp M., Smiley D.L., Heiman M.L. Ghrelin induces adiposity in rodents. Nature. 407:2000;908-913
13. Wren A.M., Seal L.J., Cohen M.A., et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab. 86:2001;5992
14. Cummings D.E., Purnell J.Q., Frayo R.S., Schmidova K., Wisse B.E., Weigle D.S. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes. 50:2001;1714-1719
15. Tschöp M., Weyer C., Tataranni P.A., Devanarayan V., Ravussin E., Heiman M.L. Circulating ghrelin levels are decreased in human obesity. Diabetes. 50:2001;707-709
16. Cummings D.E., Clement K., Purnell J.Q., et al. Elevated plasma ghrelin levels in Prader Willi syndrome. Nat Med. 8:2002;643-644
17. DelParigi A., Tschop M., Heiman M.L., et al. High circulating ghrelin a potential cause for hyperphagia and obesity in Prader-Willi syndrome. J Clin Endocrinol Metab. 87:2002;5461-5464
18. Tanaka M., Naruo T., Muranaga T., et al. Increased fasting plasma ghrelin levels in patients with bulimia nervosa. Eur J Endocrinol. 146:2002;R1-R3
19. Rohner-Jeanrenaud F., Jeanrenaud B. Obesity, leptin, and the brain. N Engl J Med. 334:1996;324-325
20. Kupersmith M.J., Gamell L., Turbin R., Peck V., Spiegel P., Wall M. Effects of weight loss on the course of idiopathic intracranial hypertension in women. Neurology. 50:1998;1094-1098
21. Tanaka M., Naruo T., Nagai N., et al. Habitual binge/purge behavior influences circulating ghrelin levels in eating disorders. J Psychiatr Res. 37:2003;17-22
22. Shiiya T., Nakazato M., Mizuta M., et al. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab. 87:2002;240-244
23. Druce M., Bloom S.R. Central regulators of food intake. Curr Opin Clin Nutr Metab Care. 6:2003;361-367
24. Herzog H. Neuropeptide Y and energy homeostasis insights from Y receptor knockout models. Eur J Pharmacol. 480:2003;21-29